Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
All Genders
Healthy Volunteers
ID06909344

Effectiveness and Safety of 577-nm Diode Laser in the Treatment of Non-Inflammatory Acne

Led by Al-Azhar University · Updated on 2025-04-03

50

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the clinical effectiveness and safety of a 577 nm diode laser to treat non-inflammatory acne, specifically acne comedones. Acne vulgaris commonly affects adolescents and young adults, often causing scarring and lowered self-esteem. This study aims to explore laser treatment as an alternative to traditional topical and oral medications, which may have side effects or compliance challenges. The laser targets sebaceous glands and bacteria involved in acne development to reduce lesions. In this study, all patients receive sessions of the 577 nm diode laser treatment on one side of their face while the other side serves as an untreated control for comparison. The treatment focuses on reducing comedonal lesions without other interventions applied to the control side. This approach allows direct evaluation of the laser's effect within the same individual over time. Participants will be assessed clinically before and after treatment, with the main outcome being the reduction in the number of comedones measured over three months. Researchers will monitor safety and treatment responses during this period. The entire study involves adults aged 18 to 40 years who have at least 10 comedonal lesions on both sides of the face. This setup helps gather detailed information about the laser's potential in managing non-inflammatory acne.

CONDITIONS

Brief Title

577-nm Diode Laser in the Treatment of Non -Inflammatory Acne

Who Can Participate

Age: 18Years - 40Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with acne comedones
  • Patients aged 18 to 40 years
  • At least 10 comedonal lesions on both halves of the face
Not Eligible

You will not qualify if you...

  • Patients with systemic diseases that interfere with healing
  • Patients with photosensitivity
  • Pregnant or lactating females
  • Previous topical, systemic, laser, surgical treatment or use of comedogenic drugs in the last 3 months
  • Presence of skin cancer or suspicious skin lesions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to 3 months

Participants receive sessions of the 577 nm Diode laser treatment on one side of the face while the other side serves as a control without intervention.

Multiple treatment sessions over the course of the study

Follow-up

Duration - 3 months

Participants are assessed for reduction in the number of comedones through clinical evaluation before and after treatment.

1 to 2 visits for clinical assessment

Trial Site Locations

Total: 1 location

1

Azhar Assuit university hospital

Asyut, Assuit, Egypt, 71511

Actively Recruiting

Loading map...

Research Team

H

Hala Hasan Shehata, resident of dermatology

E

Essam El Din Mohamed Mohamed, Professor of Dermatology

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.

John S Barbieri, Natalie Spaccarelli, David J Margolis...

https://pubmed.ncbi.nlm.nih.gov/30296534

A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris.

Ifigeneia Mavranezouli, Caitlin H Daly, Nicky J Welton...

https://pubmed.ncbi.nlm.nih.gov/35789996